Emergent Biosolutions Competitors and Similar CompaniesClear all

Emergent Biosolutions's competitors and similar companies include Valneva, LTS Lohmann Therapie-Systeme and Xoc Pharmaceuticals.
Emergent Biosolutions
Emergent Biosolutions
Emergent Biosolutions is a biopharmaceutical company that provides vaccines and therapeutics against public health threats.
Valneva
Valneva
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.
LTS Lohmann Therapie-Systeme
LTS Lohmann Therapie-Systeme
LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.
Xoc Pharmaceuticals
Xoc Pharmaceuticals
Xoc Pharmaceuticals is a biopharmaceutical company focused on the development of innovative therapeutics.
Founding Date
Founding Date
1998
Founding Date
2013
Founding Date
1984
Founding Date
2013
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Gaithersburg, US HQ
Mississauga, CA
Winnipeg, CA
Dublin, IE
London, GB
Canton, US
Lansing, US
see more
Locations
Saint-Herblain, FR HQ
Wien, AT
Kirkland, CA
Lyon, FR
Solna, SE
Fleet, GB
Livingston, GB
see more
Locations
Andernach, DE HQ
Shanghai, CN
West Caldwell, US
Locations
Los Gatos, US HQ
Employees
Employees
90044% decrease
Employees
713
Employees
2991% increase
Employees
N/A
Valuation ($)
Valuation ($)
493.6 m
Valuation ($)
482.5 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$742.9m (FY, 2025)
Revenue (est.)
€157.9m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$326.2m (FY, 2025)
Cost of goods
€8.2m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$416.7m (FY, 2025)
Gross profit
€177.7m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
$52.6m (FY, 2025)
Net income
(€115.2m) (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 34.5m
Total funding raised
$ 51.7m
Total funding raised
N/A
Total funding raised
$ 30m
For sources of this data, please see the company profile

View Company Profiles

Valneva
HQ
Saint-Herblain, FR
Employees
713

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.

View company
LTS Lohmann Therapie-Systeme
HQ
Andernach, DE

LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.

View company
Xoc Pharmaceuticals
HQ
Los Gatos, US

Xoc Pharmaceuticals is a biopharmaceutical company focused on the development of innovative therapeutics.

View company